People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

If your goal for 2026 is to boost your health, sharpen your mind, or simply feel your best, you don’t have to look far for ...

Inside Michigan Tech's Aging, Cognition and Action Lab, space debris rains down on a screen as players scramble to deflect it ...

According to the release, Southwoods can offer this therapy with the new HYDRO Robotic System, a treatment for men with ...

Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...

Fakeeh Health | CEO – Fakeeh University Hospital, stated: “This strategic partnership with Verita Neuro reflects our ...

Ferring Pharmaceuticals and Theralase® Technologies Inc. are pleased to announce that they have entered into a collaborative clinical development agreement ("Agreement") on January 9, 2026. The ...

CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...

Explore the significant impact of obesity on multiple sclerosis (MS) progression, including increased symptoms, disability, and comorbidities. Learn how to manage weight effectively with professional ...